Literature DB >> 5623955

Studies on persistent infections of tissue culture. VI. Reversible changes in Newcastle disease virus populations as a result of passage in L cells or chick embryos.

J E Rodriguez, V Ter Meulen, W Henle.   

Abstract

Populations of the Victoria strain of Newcastle disease virus (NDV), reisolated from persistently infected L-cell cultures and passed twice in the embryonated hen's egg (NDV(L-E-2)), were found to differ strikingly from the original, chick embryo-adapted virus (NDV(o)). After exposure of L cells to NDV(o) at high multiplicities of infection, all cells became abortively infected; they produced only small aggregates of viral antigen and few, if any, infectious virus particles, but they yielded large amounts of interferon. No cytopathic effects (CPE) were noted, and the cultures survived readily as viral carriers. In contrast, NDV(L-E-2) yielded under similar conditions large quantities of viral antigen and infectious virus particles, but no detectable interferon, and the cultures were rapidly destroyed. This change in "virulence" was at least partially reversible by further serial passages of NDV(L-E-2) in chick embryos, as was evident from a consecutive decrease in CPE with a concomitant increasingly rapid recovery of the L-cell cultures, gradually diminishing yields of infectious viral progeny, and the returning of a capacity to induce interferon synthesis. Thus, NDV(L-E-16) resembled NDV(o) in many aspects, except for a less striking reduction in its ability to replicate in L cells. Although a selection of viral variants under the given sets of conditions has not been entirely excluded, the establishment of "avirulence" appears to be largely explained by a gradual accumulation of noninfectious, interferon-inducing components in the course of serial passages in the embryonated hen's egg, and the acquisition of "virulence" by a loss of these components. The evidence is as follows. (i) By a step-wise decrease in the dose of virus and restriction of the analyses to the first infectious cycle, a multiplicity of infection was ultimately reached for all "avirulent" populations at which infected cells produced normal yields of infectious viral progeny; i.e., the interferon-inducing components were diluted to noneffective levels. The lowest multiplicity which resulted in a measurable reduction in infectious virus replication was also the last one to induce detectable interferon synthesis. (ii) All viral clones derived from "avirulent" populations behaved like NDV(L-E-2) rather than like the parent viral suspensions, except that some of them elicited small amounts of interferon in L cells. The interferon-inducing components were reduced or lost in the cloning procedures. The nature of the interferon-inducing components has not been established. These components, which were neutralized by rabbit sera against "virulent" NDV(L-E-2) populations, may represent largely inactive or incomplete virus particles; however, the infectious virus-hemagglutinin ratios of "avirulent" populations were mostly of an order similar to those of "virulent" populations. The interferon-inducing components aborted the infectious process in cells simultaneously invaded by infectious virus particles. The implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5623955      PMCID: PMC375498     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Host-controlled variation in NDV.

Authors:  J W DRAKE; P A LAY
Journal:  Virology       Date:  1962-05       Impact factor: 3.616

2.  A consideration of the mechanisms of resistance to viral infection based on recent studies of the agents of measles and poliomyelitis.

Authors:  J F ENDERS
Journal:  Trans Stud Coll Physicians Phila       Date:  1960-10

3.  Induction of Newcastle disease virus mutants with nitrous acid.

Authors:  A GRANOFF
Journal:  Virology       Date:  1961-04       Impact factor: 3.616

4.  The persistent production of small quantities of infectious Newcastle disease virus in grossly unaltered L and U12 strain cells.

Authors:  E J MASON; N KAUFMAN
Journal:  J Immunol       Date:  1961-04       Impact factor: 5.422

5.  Studies on mixed infection with Newcastle disease virus. I. Isolation of Newcastle disease virus mutants and tests for genetic recombination between them.

Authors:  A GRANOFF
Journal:  Virology       Date:  1959-12       Impact factor: 3.616

6.  Changes in activity of Newcastle disease virus after adaption to Ehrlich ascites tissue culture.

Authors:  L C DIAMOND; A E MOORE
Journal:  J Immunol       Date:  1956-08       Impact factor: 5.422

7.  The role of interferon in vaccinia virus infection of mouse embryo tissue culture.

Authors:  L A GLASGOW; K HABEL
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

8.  Studies on persistent infections of tissue cultures. IV. Evidence for the production of an interferon in MCN cells by myxoviruses.

Authors:  W HENLE; G HENLE; F DEINHARDT; V V BERGS
Journal:  J Exp Med       Date:  1959-10-01       Impact factor: 14.307

9.  Studies on persistent infections of tissue cultures. I. General aspects of the system.

Authors:  G HENLE; F DEINHARDT; V V BERGS; W HENLE
Journal:  J Exp Med       Date:  1958-10-01       Impact factor: 14.307

10.  STUDIES ON PERSISTENT INFECTIONS OF TISSUE CULTURES. V. THE INITIAL STAGES OF INFECTION OF L(MCN) CELLS BY NEWCASTLE DISEASE VIRUS.

Authors:  J E RODRIGUEZ; W HENLE
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

View more
  3 in total

Review 1.  The Journal of Virology: a personal retrospective.

Authors:  R R Wagner
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 2.  Mechanisms of persistent infections by cytopathic viruses in tissue culture. Brief review.

Authors:  R M Friedman; J M Ramseur
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

3.  Viral persistence in colorectal cancer cells infected by Newcastle disease virus.

Authors:  Suet-Lin Chia; Khatijah Yusoff; Norazizah Shafee
Journal:  Virol J       Date:  2014-05-16       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.